GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus.
Sign Up to like & getrecommendations! Published in 2021 at "Bioorganic chemistry"
DOI: 10.1016/j.bioorg.2021.104998
Abstract: Diabetes mellitus type 2 (T2D) is a group of genetically heterogeneous metabolic disorders whose frequency has gradually risen worldwide. Diabetes mellitus Type 2 (T2D) has started to achieve a pandemic level, and it is estimated… read more here.
Keywords: gpr119 agonists; type diabetes; gpr119 agonist; diabetes mellitus ... See more keywords